Lung specialists are drawing attention to recent progress in diagnosing and treating cystic fibrosis, while also calling for continued research into the disease, according to Notimérica.
The reports, published around early September 2026, coincide with awareness efforts tied to Cystic Fibrosis Day. Physicians in Málaga, Spain, have joined the observance by emphasizing the importance of early detection, Málaga Hoy reported.
Notimérica notes that experts in pulmonology point to notable advances in both diagnostic tools and therapeutic options. However, they stress that the work is far from complete, urging the medical community and public institutions to keep funding and pursuing investigations into the condition.
Additional coverage from Cadena SER highlights the role of physiotherapy in managing the disease. Armando Rodríguez, vice-secretary of the College of Physiotherapists of Extremadura, said that drug therapies and physical therapy must be used together for effective cystic fibrosis treatment. His comments underline a broader consensus that care requires a multidisciplinary approach.
Separately, Infobae has reported on the impact of a new triple therapy for pediatric patients, describing the evolution of treatment as a scientific milestone. The therapy has reportedly changed outcomes for children with the condition, though details on specific trial data or patient numbers were not available in the summarized material.
Cystic fibrosis is a genetic disorder that primarily affects the lungs and digestive system. While current treatments have extended life expectancy and improved quality of life for many patients, specialists maintain that gaps remain in understanding the disease’s full complexity.
What to watch next: whether new research funding and early-screening programs will follow these calls from pulmonary experts across Spain.
